ABSTRACT
Methods:
1-(3, The interaction of SH2U with hMAO isoforms was investigated fluorometrically using commercial kits.
The interaction between SH2U and hMAO was also analyzed using AutoDock 4.2.6 program.
Results: The structure of compound SH2U was confirmed using IR, Mass, 1 H-NMR and elemental analysis methods. SH2U appeared as a potent, selective, reversible and nontoxic hMAO-B inhibitor.
Mode of inhibition was found to be competitive.
Interactions of the new compound with the active site of hMAO-B were clarified using molecular modelling studies.
Conclusion:
Compound SH2U inhibited hMAO-B potently, selectively, competitively and reversibly.
The synthesized compound is found to be more potent and selective than selegiline, the known irreversible 
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